22q and two: 22q11.2 deletion syndrome and coexisting conditions
- 23 September 2018
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 176 (10) , 2203-2214
Abstract
22q11.2 deletion syndrome (DS) is the most frequent copy number variant (CNV) affecting ~1/1,000 fetuses and ~1/2,000–4,000 children, resulting in recognizable but variable findings across multiple organ systems. Patients with atypical features should prompt consideration of coexisting diagnoses due to additional genome‐wide mutations, CNVs, or mutations/CNVs on the other allele, unmasking autosomal recessive conditions. Importantly, a dual diagnosis compounds symptoms and impacts management. We previously reported seven patients with 22q11.2DS and: SCID, Trisomy 8 mosaicism, Bernard‐Soulier, and CEDNIK syndromes. Here we present six additional unreported patients with 22q11.2DS and concurrent diagnoses. Records on 1,422 patients with 22q11.2DS, identified via FISH, microarray, or MLPA, followed in our 22q and You Center at the Children's Hospital of Philadelphia (CHOP) were reviewed to identify a dual diagnosis. In addition to our seven previously reported cases, we identified an additional six with 22q11.2DS and another coexisting condition identified via: molecular/cytogenetic studies, newborn screening, coagulation factor studies, or enzyme testing; these include CHARGE syndrome (CHD7 mutation), cystic fibrosis, a maternally inherited 17q12 deletion, G6PD deficiency, von Willebrand disease, and 1q21.1 deletion, resulting in an incidence of dual diagnoses at our center of 0.9%. The range of dual diagnoses identified in our cohort is notable, medically actionable, and may alter long‐term outcome and recurrence risk counseling. Thus, our findings may support testing patients with 22q11.2DS using a combination of microarray, mutational analysis of the other allele/WES, to ensure appropriate personalized care, as formulating medical management decisions hinges on establishing the correct diagnoses in their entirety.Keywords
Funding Information
- CYTOGENETIC AND MOLECULAR STUDIES OF CHROMOSOME 22 (R01 CA039926)
- GENETIC MODIFIERS FOR 22Q 11.2 DELETION SYNDROME (R01 HL084410)
This publication has 63 references indexed in Scilit:
- Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DSJournal of Medical Genetics, 2012
- Functional outcomes of adults with 22q11.2 deletion syndromeGenetics in Medicine, 2012
- Sex differences in reproductive fitness contribute to preferential maternal transmission of 22q11.2 deletionsJournal of Medical Genetics, 2011
- Practical Guidelines for Managing Patients with 22q11.2 Deletion SyndromeThe Journal of Pediatrics, 2011
- Deletion 17q12 Is a Recurrent Copy Number Variant that Confers High Risk of Autism and SchizophreniaThe American Journal of Human Genetics, 2010
- Unmasking of a Recessive SCARF2 Mutation by a 22q11.12 de novo Deletion in a Patient with Van den Ende-Gupta SyndromeMolecular Syndromology, 2010
- Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in miceJournal of Clinical Investigation, 2009
- Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalitiesNature Genetics, 2008
- Recurrent Reciprocal Genomic Rearrangements of 17q12 Are Associated with Renal Disease, Diabetes, and EpilepsyThe American Journal of Human Genetics, 2007
- T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndromeBlood, 2004